AIDS-related Funding Opportunity Announcements

NIMH Notices of Funding Opportunities

Request for Applications (RFA)

RFA-MH-26-105: Multimodal Artificial Intelligence to Accelerate HIV Clinical Care (R01 Clinical Trial Optional) 

RFA-MH-26-110: Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R01 Clinical Trial Not Allowed) 

RFA-MH-26-111: Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R21 Clinical Trial Not Allowed)  

RFA-AI-24-023: U.S.-South Africa Program for Collaborative Biomedical Research – Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional) 

Notice of Special Interest (NOSI)

NOT-MH-23-100: Notice of Data Sharing Policy for the National Institute of Mental Health 

NOT-MH-23-250: Notice of Special Interest (NOSI): Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults 

NOT-MH-23-265: Notice of Special Interest (NOSI): Mental Health Comorbidities in HIV Prevention and Treatment 

NOT-MH-23-275: Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets 

NOT-MH-23-350: Notice of Special Interest (NOSI): Advancing Data Science Research in HIV: Responding to a Dynamic, Complex, and Evolving HIV Epidemic with Artificial Intelligence/Machine Learning 

Program Announcement with Special Receipt, Referral, and/or Review Considerations (PAR)

PAR-23-060: Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional) 

PAR-23-061: Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Option) 

PAR-23-062: Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Option) 

PAR-24-164: Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) 

PAR-24-165: AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) 

PAR-24-233: NIMH Research Education Mentoring Program for HIV Researchers (R25 Clinical Trial Not Allowed) 

Co-Sponsored Funding Opportunities

Notice of Special Interest (NOSI)

NOT-AI-22-042: Notice of Special Interest (NOSI): Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP) 

NOT-AI-24-059: Notice of Special Interest (NOSI): Ending the HIV Epidemic (EHE) 

NOT-CA-24-031: Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence/Machine Learning Tools for Improved Assessment in Biomedical and Behavioral Research 

NOT-OD-24-146: Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health 

Program Announcement with Special Receipt, Referral, and/or Review Considerations (PAR)

PAR-24-295: Emerging Global Leader Award (K43 Independent Clinical Trial Required) 

PAR-24-296: Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) 

PAR-25-143: Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) 

PAR-25-144: Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) 

PAR-25-233: Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) 

PAR-25-330: Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)